FPP finished pharmaceutical product
GDF Global Drug Facility
GHC Global Health Committee
GLC Green Light Committee
HCP health care professional
HIV human immunodeficiency virus

International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use

IFFIm International Finance Facility for Immunization
IOM Institute of Medicine
IQA internationally quality-assured
MDR TB multidrug-resistant tuberculosis
MSF Médecins Sans Frontières
MSH Management Sciences for Health
M.tb. Mycobacterium tuberculosis
NGO nongovernmental organization
NRA national regulatory authority
NTP national TB control programme
OpenMRS Open Medical Record System
PAS 4-aminosalicylic acid
PEPFAR U.S. President’s Emergency Plan for AIDS Relief
PMDT programmatic management of drug-resistant tuberculosis
PQ prequalified (by WHO)
PRI Program-Related Investment
QA quality-assured/quality assurance
QC quality control
SCM supply chain management
SCMS Supply Chain Management System (PEPFAR/USAID)
SLD second-line anti-TB drug
SLDAII Second-Line Drug Access Improvement Initiative
SMS short message service
SRA stringent regulatory authority

The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement